New York State Common Retirement Fund Rain Therapeutics Inc. Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$0.82 - $1.42 $62,990 - $109,081	-76,818 Reduced 98.23%	1,382 $1,000
Q2 2023 Aug 07, 2023	BUY	$1.09 - $9.93 $85,238 - $776,526	78,200 New	78,200 $94,000
Q2 2022 Aug 04, 2022	SELL	$2.21 - $5.56 $13,923 - $35,028	-6,300 Reduced 97.96%	131 $1,000
Q1 2022 May 05, 2022	BUY	$5.07 - $13.68 $375 - $1,012	74 Added 1.16%	6,431 $33,000
Q4 2021 Feb 02, 2022	SELL	$11.91 - $17.0 $190 - $272	-16 Reduced 0.25%	6,357 $82,000

Q3 2021 Nov 02, 2021	BUY	$13.21 - $20.91 $964 - $1,526	73 Added 1.16%	6,373 $95,000
Q2 2021 Aug 02, 2021	BUY	$15.08 - $20.3 $95,004 - $127,890	6,300 New	6,300 $98,000

122K

Ticker RAIN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,837,400
Description
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.